Fenofibrate, a Member of the Fibrate class of Medications, has long been recognized for its Role in Promoting Cardiovascular Health.
Widely Prescribed to Manage Lipid Disorders, Fenofibrate is a key component in Medications designed to Lower Cholesterol Levels and Reduce the Risk of Cardiovascular Events.
Fenofibrate Overview:
CAS Number: 49562-28-9
Molecular Weight: 360.83
Storage Temperature: Store at Room Temperature (RT)
The Molecular Power of Fenofibrate:
Before we delve into the manufacturers and suppliers, let’s take a moment to appreciate the molecular structure of fenofibrate. With a molecular formula of C20H21ClO4, fenofibrate is a powerful compound designed to modulate lipid metabolism and improve cardiovascular outcomes. Its chemical structure plays a crucial role in its ability to lower triglyceride and cholesterol levels.
Fenofibrate API Manufacturers and Suppliers:
AbbVie Inc.:
AbbVie, a global biopharmaceutical company, stands out as a major player in the production of fenofibrate API. Renowned for its commitment to research and development, AbbVie contributes significantly to the availability of fenofibrate for cardiovascular health formulations.
Cipla Limited:
Cipla, a leading pharmaceutical company based in India, is actively involved in the manufacturing of fenofibrate API. The company’s dedication to producing high-quality medications extends to its role in providing fenofibrate for a global market.
Daiichi Sankyo Company, Limited:
Daiichi Sankyo, a Japanese pharmaceutical company, is a key player in the production of fenofibrate API. With a focus on cardiovascular health, the company ensures the availability of fenofibrate to address the specific needs of patients with lipid disorders.
Fenofibrate’s Role in Cardiovascular Health:
Fenofibrate’s mechanism of action involves activating peroxisome proliferator-activated receptor alpha (PPAR-α), a nuclear receptor that regulates genes involved in lipid metabolism. By modulating lipid levels, fenofibrate helps reduce the risk of cardiovascular events, making it a crucial component in the management of conditions such as hypertriglyceridemia.
As cardiovascular Health continues to be a Global Priority, The Role of Fenofibrate API manufacturers and suppliers becomes increasingly significant. Companies like AbbVie, Cipla, and Daiichi Sankyo exemplify the dedication required to ensure a steady supply of fenofibrate for formulations aimed at improving lipid profiles and preventing cardiovascular complications.